Pulmolines is a group of studies investigating the obstructive airway, pulmonary disease, and ageing. The ATLANTIS cohort within Pulmolines was designed to focus on the prevalence and impact of asthma. ATLANTIS recruited over 700 participants aged 18 to 65 years who had received a clinical asthma diagnosis at least 6 months before recruitment from nine countries (Brazil, Canada, China, Germany, Italy, Spain, the Netherlands, the United Kingdom, and the United States of America). Around 100 participants without asthma were also recruited to serve as a control group. Control participants were also aged 18 to 65 years, from one of the nine recruitment countries and had no symptoms of asthma or chronic obstructive pulmonary disease. Data was collected from 2014, and all participants were followed up at baseline, 6 months, and 12 months.
Study design
Cohort, Cohort - clinical
Number of participants at first data collection
773 (participants)
99 (control participants)
Age at first data collection
18 - 65 years (participants)
18 - 65 years (control participants)
Participant year of birth
Varied (participants)
Varied (control participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2014
Primary Institutions
Chiesi Farmaceutici S.p.A.
Chiesi Pharmaceuticals BV
German Center for Lung Research (Deutsches Zentrum für Lungenforschung, DZL)
Kiel University (Christian-Albrechts-Universität zu Kiel, CAU)
University Medical Center Groningen (Universitair Medisch Centrum Groningen, UMCG)
Links
umcgresearchdatacatalogue.nl/UMCG/ssr-catalogue/all/cohorts/ATLANTIS
clinicaltrials.gov/study/NCT02123667
Profile paper DOI
Funders
Chiesi Farmaceutici
Ongoing?
No
Data types collected
Quantitative data collection
Qualitative data collection
Neuroimaging data collection
Linked or secondary data
Engagement
Keywords
Consortia and dataset groups